XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (12,991,324) $ (6,498,233)
  Adjustments to reconcile net loss to cash provided by operating activities    
Stock based compensation expense 355,553 319,809
Depreciation and amortization 3,706,908 3,348,008
Gain on forgiveness of debt (4,222,000) 0
Gain on sale of assets (1,424) (12,344)
Bad debt expense 737,002 65,443
Increase (decrease) in fair value of derivative warrant liability 23,287,535 (1,587,782)
Loss (gain) on commodity derivative contracts 1,925,158 (4,484,798)
Net cash settlements on commodity derivatives (1,960,424) 4,781,183
Amortization of debt discount and deferred costs 0 47,826
Changes in operating assets and liabilities, net of effect of acquisition    
Accounts receivable and other receivables (8,093,446) 4,986,003
Inventory (4,398,143) 3,711,239
Prepaid expenses 1,836,390 1,834,361
Accounts payable 4,828,808 (269,740)
Accrued expenses 120,577 (2,150,272)
Other assets (84,953) (378,547)
Net cash provided by operating activities 5,046,217 3,712,156
Cash flows from investing activities    
Acquisition 0 (1,822,690)
Internally developed software 0 (49,229)
Purchase of fixed assets (2,748,528) (1,526,379)
Proceeds from sale of fixed assets 1,600 22,844
Net cash used in investing activities (2,746,928) (3,375,454)
Cash flows from financing activities    
Payments on finance leases (252,175) (162,312)
Proceeds from exercise of options and warrants to common stock 2,829,228 0
Contributions received from noncontrolling interest and redeemable noncontrolling interest 0 21,000,000
Line of credit (payments) proceeds, net 1,031,737 (3,276,230)
Payments on note payable (1,836,511) (8,618,202)
Net cash provided by financing activities 1,772,279 13,317,899
Net change in cash, cash equivalents and restricted cash 4,071,568 13,654,601
Cash, cash equivalents, and restricted cash at beginning of the period 10,995,169 4,199,825
Cash, cash equivalents, and restricted cash at end of period 15,066,737 17,854,426
SUPPLEMENTAL INFORMATION    
Cash paid for interest 483,285 562,259
Cash paid for taxes 0 0
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Exchanges of Series B Preferred Stock into common stock 4,747,250 0
Accretion of discount on Series B and B1 Preferred Stock 507,282 1,471,238
Dividends-in-kind accrued on Series B and B1 Preferred Stock (258,138) 704,716
Initial adjustment of carrying amount redeemable noncontrolling interests 0 9,091,068
Accretion of redeemable noncontrolling interest to redemption value 761,993 12,348,238
Series B Preferred Stock    
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Conversion of Series B and B1 Preferred Stock into Common Stock 8,446,836 0
Dividends-in-kind accrued on Series B and B1 Preferred Stock 0  
Series B1 Preferred Stock    
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Conversion of Series B and B1 Preferred Stock into Common Stock 12,046,441 $ 3,368,474
Dividends-in-kind accrued on Series B and B1 Preferred Stock $ 0